Contact · Clinical trial technology coverage
Reach the Sudova Agent team
Questions about our RTSM and eClinical coverage, corrections to anything published here, or a platform you think we should look at.
Before you write
What to send us
Corrections get the fastest attention, especially when they name the page and the specific detail that is wrong. Coverage suggestions are welcome too, particularly for RTSM or eClinical systems evaluated by US sponsors that we have not included. If your question is about a study design rather than our coverage, tell us the study shape, and we can point you to the relevant guide.
Someone reads every message that arrives here. Nothing is routed to a sales queue, because there is no sales queue.
Send this
Fastest first
Corrections
A wrong detail on a page we publish
Name the page and the specific claim or reading that has drifted. That is the fastest thing for us to verify and fix.
Coverage
A platform or capability we have missed
RTSM, IRT, eCOA, ePRO, CTMS, eTMF, EDC, eConsent — if a US sponsor team runs it and we have not covered it, say so.
Study shape
Which guide fits your trial
Describe the arms, the countries, and whether supply ships direct to site. We will point you at the guide closest to it.
Feedback
How a page reads in practice
If a comparison left out the thing your team actually weighs, that gap is worth sending and we will look at it.
If you would rather read first, the capability guides walk through the systems we cover.
Where our help stops
What we cannot help with
Sudova Agent does not sell platforms and cannot recommend a vendor for a specific protocol. We do not provide pricing, contract terms, or regulatory guidance. If your question is about validation documentation for a live trial, that belongs with the platform vendor and your quality group.
Being clear about this saves everyone a round of email — and it means any answer you do get from us is about the coverage, not a pitch dressed as one.
On vendor selection and commercial terms this page has no answer to give. Bring the study-design or coverage question instead and it belongs here.
Write to us
How to reach us
Write to us through the form, or call the number below. Form submissions collect your name, email address, and message, which we handle according to the privacy policy linked in the footer of every page.
Phone
+1-617-555-0184Office
1201 Innovation Drive, Suite 300
Cambridge, MA 02142, USA
Hours
Monday–Friday, 9:00 AM – 6:00 PM
Where to find us
The Cambridge office
Sudova Agent
1201 Innovation Drive
Suite 300
Cambridge, MA 02142
USA
Monday–Friday, 9:00 AM – 6:00 PM
Visitors are welcome by arrangement — send a note through the form first so someone is at the desk when you arrive.
Before you send
Response times
We aim to reply within two business days. Correction requests that name a specific page and detail usually get a faster answer, because they can be checked without a research pass. If your message needs input from more than one person here, expect a longer turnaround and a short note telling you so.
Same day, often
A correction with the page and the detail named. Those are read first.
Within two business days
Coverage suggestions, general feedback, and questions about a guide.
Longer, with a note
Anything needing input from more than one person here. You will hear why, and roughly when.
Outside this page
Vendor selection, pricing, contract terms, and regulatory guidance are not answered here.
If you want a platform covered, include its name, the modules it spans, and roughly how it is positioned for US trials. A link to the vendor's own product page is helpful. We evaluate suggestions against our existing coverage and add them when there is enough public material to write something accurate.
If you came here to read
Where to go next
Not every visit ends in a message. If the depot walk is what you were after, these are the three places most people start.
Platform comparison
RTSM/IRT and the eClinical suite, side by side
The row-by-row read on where the two stacks meet and where they diverge for US sponsors.
Capability guides
Randomisation, supply, eConsent, eCOA
One chapter per capability, written for clinical operations teams rather than for buyers.
Evaluation method
How we assess and what we refuse to claim
The criteria we hold every clinical technology note against, and the limits of what we check.
Questions about a policy page instead? They are one click from the footer of every page, or email [email protected].